Kaplan Fox & Kilsheimer LLP Encourages ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors to Contact the Firm Before October 5, 2026

Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.
PR Newswire

SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

SueWallSt reminds purchasers of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities of a pending securities class action brought on behalf ...
PR Newswire

SPRY Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: ...

Kaplan Fox Class Action Reminder: ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Lead Plaintiff Deadline is October 5, 2026

Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.
financialcontent

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY

Pomerantz LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at ...
MarketScreener

ALK appoints Tina Abild Olesen as Executive Vice President for Corporate, Portfolio and Product Strategy

ALK today announced the appointment of Tina Abild Olesen as Executive Vice President for Corporate, Portfolio and Product Strategy (CPPS), effective 1 October 2026. Tina succeeds Jacob Glenting, who ...